SECsense Logo

Benitec Biopharma Inc. 8-K/A Filing: Key Amendments and Insights

$BNTC
Form 8-K/A
Filed on: 2024-12-31
Source
Benitec Biopharma Inc. 8-K/A Filing: Key Amendments and Insights

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Benitec Biopharma Inc.
  • CIK: 0001808898
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001808898
  • Address: 3940 Trust Way, Hayward, CA 94545
  • Phone Number: 510-780-0819
  • NASDAQ Ticker Symbol: BNTC
  • Common Stock Par Value: $0.0001
  1. Filing Details:
  • Form Type: Amendment to Current Report on Form 8-K/A
  • Original Filing Date: December 13, 2024
  • Amendment Filing Date: December 27, 2024
  • SEC File Number: 001-39267
  • Company's Federal Employer Identification Number (EIN): 84-4620206
  1. Purpose of the Filing:
  • This amendment is intended to supplement the Company’s disclosures specifically under Item 5.02 of the Initial Form 8-K filed previously. It is important to note that no modifications were made to the other information contained in the Initial Form 8-K.
  1. Context of Reporting:
  • The reporting period for the amendment is limited to a single day: December 27, 2024.
  1. XBRL Information:
  • The document is formatted using XBRL (eXtensible Business Reporting Language), which is commonly used for regulatory filings to facilitate better data analysis.

This summary encapsulates the essential details of the filing, capturing the necessary information about the company, the nature of the filing, and the specific period covered.